<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine whether soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules are affected in <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo>, we measured serum levels of <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase (CK), soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (sVCAM-1), soluble intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (sICAM-1), soluble (s) E-selectin, and fibrin and fibrinogen degradation products (FDP) in 25 patients with Duchenne <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (DMD), 7 with Becker <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo>, 7 with Fukuyama type <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo>, 6 with myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> (MyD), and 5 with <z:hpo ids='HP_0007269'>spinal muscular atrophy</z:hpo> (SMA) type 2, and also serum sVCAM-1, sICAM-1, and sE-selectin in 9 healthy controls </plain></SENT>
<SENT sid="1" pm="."><plain>The levels of sVCAM-1 in the patients with DMD were 367.0-852.0 ng/ml (552.8 +/- 23.1) and significantly elevated than those in the patients with MyD, SMA type 2, and controls </plain></SENT>
<SENT sid="2" pm="."><plain>The levels of sICAM-1 and sE-selectin in the patients with <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> were 0.2-376.0 ng/ml and 17.9-119.0 ng/ml, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>They were also elevated than those in the patients with SMA type 2 and controls, but not significantly </plain></SENT>
<SENT sid="4" pm="."><plain>The levels of sVCAM-1 and sE-selectin in the patients with DMD significantly correlated with age </plain></SENT>
<SENT sid="5" pm="."><plain>There was no correlation between the levels of soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules and those of CK or FDP in any groups </plain></SENT>
<SENT sid="6" pm="."><plain>These changes of soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules may reflect the process of muscle destruction and endothelial cell activation in <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> </plain></SENT>
</text></document>